Form 20-F/A - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0000950170-24-134775
Filing Date
2024-12-10
Accepted
2024-12-10 08:37:27
Documents
5
Period of Report
2024-12-10

Document Format Files

Seq Description Document Type Size
1 20-F/A ipa-20241210.htm 20-F/A 68121
2 EX-12.1 ipa-ex12_1.htm EX-12.1 9792
3 EX-12.2 ipa-ex12_2.htm EX-12.2 9819
4 EX-13.1 ipa-ex13_1.htm EX-13.1 8188
5 EX-13.2 ipa-ex13_2.htm EX-13.2 8321
  Complete submission text file 0000950170-24-134775.txt   105279
Mailing Address 3204-4464 MARKHAM ST. VICTORIA A1 V8Z 7X8
Business Address 3204-4464 MARKHAM ST. VICTORIA A1 V8Z 7X8 6048060626
ImmunoPrecise Antibodies Ltd. (Filer) CIK: 0001715925 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0430
Type: 20-F/A | Act: 34 | File No.: 001-39530 | Film No.: 241537225
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)